PRESS RELEASE
News
-
-
PRESS RELEASE
Blue Lagoon Toll Mill Partner Makes $1 Million Strategic Investment
Blue Lagoon Resources Inc. is pleased to announce the successful closure of a non-brokered, oversubscribed, private placement offering for its Dome Mountain Project, with the majority of the offering taken by the Company's toll milling partner. The project, holding both environmental and mining permits, has significant exploration potential, and the investment by Nicola Mining Inc. further validates the project's value. The press release includes forward-looking statements and contact information for further details. -
PRESS RELEASE
Blue Lagoon Announces Private Placement
Blue Lagoon Resources Inc. (CSE:BLLG)(FSE:7BL)(OTCQB:BLAGF) announces a private placement offering of common shares (the 'Private Placement') of up to $1,000,000 at a price of $0.14 per share. Proceeds will be used to advance the Company's Dome Mountain gold project. For further information, please contact Rana Vig, President and Chief Executive Officer, at 604-218-4766 or email rana@ranavig.com. -
-
PRESS RELEASE
Blue Lagoon Update on Dome Mountain Gold Project
-
PRESS RELEASE
Blue Lagoon Announces Appointment of New CFO
-
PRESS RELEASE
Blue Lagoon Announces Completion of Private Placement
-
PRESS RELEASE
Blue Lagoon Announces Private Placement
-
PRESS RELEASE
Blue Lagoon Submits Final Mining Permit Application
-
![Accesswire](/assets/images/accesswire-inline.png)
-
Southern Energy Corp. Announces Payment of Interest in-Kind to its 8% Convertible Unsecured Subordinated Debentures
-
APWG 2024 Cybercrime Research Conference Extends Submission Deadline to July 7
-
Product Creation Studio Partners With PatchClamp Medtech Inc. to Develop Revolutionary Dural Repair System
-
XS Financial Enters Into Definitive Agreement to Be Taken Private
-
TRU Engages Investor Relations Specialists HE Capital Markets
![EQS Group](/assets/images/eqs-group.png)
-
DEFENCE’S ARM-X ANTI-CANCER VACCINE INHIBITS GROWTH OF PRE-ESTABLISHED OVARIAN CANCER RESULTING IN COMPLETE RESPONSES IN TREATED ANIMALS
-
Agreement reached with iBusiness Funding to acquire Funding Circle’s US business
-
Cairn Homes Plc: Transaction in Own Shares
-
Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
-
HORNBACH Group delivers strong Q1 2024/25 results increasing earnings per share y-o-y by 44% – full-year outlook confirmed unchanged
![Les Echos](/assets/images/les-echos.png)
-
Cie du Bois Sauvage: Buy back of own shares – week from 17/06/2024 to 21/06/2024
-
Signing of the share purchase agreement for the acquisition of a majority stake in Neoen by Brookfield from Impala and other shareholders and of a tender agreement between Brookfield and Bpifrance
-
Schneider Electric launches an offering of bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2031 for a nominal amount of €750 million and a concurrent repurchase of its outstanding OCEANEs due 2026
-
Gimv increases its stake in TINC – Gimv and Belfius conclude agreement in principle on the sale of the shares of Belfius Insurance in TINC
-
Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2024